Is DXCM a good stock to buy? We came across a bullish thesis on DexCom, Inc. on Part-Time Compounder’s Substack by Francesco ...

Dexcom G7 CGMs contain a complex electronic assembly within a wearable package that stands up to the rigors of everyday ...

Let’s dig into the relative performance of DexCom (NASDAQ:DXCM) and its peers as we unravel the now-completed Q4 patient ...

They offer investors very different value propositions.

Apple Watch displays real-time glucose data from CGM devices like the Dexcom G7, while Apple continues to develop ...

DexCom's Q1 results may see strong growth from G7 uptake and CGM demand, but pricing mix and rising investments could weigh on margins.

The multi-billion dollar CGM market is expected to experience substantial, double-digit percentage growth over the next five ...

Dexcom develops continuous glucose monitoring (CGM) devices. Diabetic patients use these to track their glucose levels in ...

In terms of stakeholders revenue share in 2022, the Mobile Operators and Device Vendors segments represented more than ...

An astonishing 25% of veterans who receive VA care are dealing with diabetes and those who have served are nearly twice as ...

Senseonics VP of Product Development Hari Sree explains the tech behind the Eversense 365-day CGM and what’s next in the ...

Drugmakers won't be the only ones cashing in on the rising popularity of weight loss medicines.